Randall Pollard
Keine laufenden Positionen mehr
Vermögen: 5 405 $ am 31.05.2024
Profil
Randall E.
Pollard worked as the Controller, Chief Financial & Accounting Officer at Akorn, Inc. in 2015.
He also worked as the Head-Accounting & Reporting at Novartis Pharmaceuticals Corp.
Additionally, he served as the Chief Financial & Accounting Officer at Cue Health, Inc. from 2022 to 2024.
Mr. Pollard holds an MBA from Fairleigh Dickinson University and an undergraduate degree from The Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CUE HEALTH INC.
0,05% | 05.03.2024 | 79 479 ( 0,05% ) | 5 405 $ | 31.05.2024 |
Ehemalige bekannte Positionen von Randall Pollard
Unternehmen | Position | Ende |
---|---|---|
CUE HEALTH INC. | Finanzdirektor/CFO | 24.05.2024 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Comptroller/Controller/Auditor | - |
AKORN, INC. | Finanzdirektor/CFO | 30.10.2015 |
Ausbildung von Randall Pollard
The Pennsylvania State University | Undergraduate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CUE HEALTH INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |